Aligos Therapeutics, Inc.
USD5.60
+0.17 (+3.13%)
CEO
Lawrence Blatt
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.38
Prev. Close
$5.43
Day Low
$5.38
Day High
$5.74
52W Low
$4.80
52W High
$13.69
Market Cap
$0.03B
Volume
0.03M
| -1.9 |
| 31 Dec 2023 | FY | 100.0% | -564.6% | -95.2% | -57.9% | 0.12 | 5.90 | -4.7 |
| 31 Dec 2022 | FY | 100.0% | -690.6% | -92.4% | -65.5% | 0.12 | 4.03 | -10.6 |
| 31 Dec 2021 | FY | 100.0% | -2944.1% | -69.5% | -54.5% | 0.08 | 5.25 | -92.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -49.3% | -40.9% | 0.06 | 8.26 | -217.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 80.5% | -35.7% | -0.22 | 8.70 | -155.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 101.3% | -12.9% | -1.01 | 12.33 | -564.1 |
| -1.2 |
| 30 Sept 2025 | Q3 | 100.0% | -4256.0% | -43.9% | -28.7% | 0.08 | 4.70 | -0.8 |
| 30 Jun 2025 | Q2 | 73.2% | -1643.8% | -15.6% | -11.8% | 0.07 | 6.31 | -1.2 |
| 31 Mar 2025 | Q1 | 100.0% | 13854.7% | 37.0% | 28.6% | 0.07 | 7.56 | 0.4 |
| 31 Dec 2024 | Q4 | 100.0% | -13060.4% | 283.5% | -117.2% | -0.29 | 2.86 | -0.8 |
| 30 Sept 2024 | Q3 | 100.0% | -1517.7% | -38.4% | -21.8% | 0.18 | 3.81 | -0.7 |
| 30 Jun 2024 | Q2 | 42.5% | 477.0% | 7.5% | 4.7% | 0.15 | 4.23 | 2.9 |
| 31 Mar 2024 | Q1 | 100.0% | -3535.8% | -58.3% | -27.3% | 0.18 | 6.25 | -2.7 |
| 31 Dec 2023 | Q4 | 100.0% | -1040.4% | -30.3% | -18.4% | 0.12 | 5.90 | -3.7 |